Guohua Rong
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The molecular tumor burden index as a response evaluation criterion in breast cancer.
Journal: Signal transduction and targeted therapy
Published: March 24, 2021
DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis.
Journal: Annals of translational medicine
Published: March 12, 2021
Mutational characteristics determined using circulating tumor DNA analysis in triple-negative breast cancer patients with distant metastasis.
Journal: Cancer communications (London, England)
Published: May 07, 2020
Taxotere-induced WNT16 Expression in Carcinoma-Associated Fibroblasts Might Associate with Progression and Chemoresistance of Breast Cancer.
Journal: Annals of clinical and laboratory science
Published: May 06, 2020
Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China.
Journal: Cancer communications (London, England)
Published: January 01, 2020
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers.
Journal: Breast (Edinburgh, Scotland)
Published: December 14, 2019
Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer.
Journal: Oncology letters
Published: February 13, 2017
Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology.
Journal: Medical oncology (Northwood, London, England)
Published: January 31, 2016
Last Updated: 09/26/2026